| Literature DB >> 27439352 |
Jing Hieng Ngu1,2, George Boon Bee Goh1,2, Zhongxian Poh3, Roy Soetikno1,2.
Abstract
The prevalence of non-alcoholic fatty liver disease (NAFLD) is increasing rapidly with the obesity and diabetes mellitus epidemics. It is rapidly becoming the most common cause of liver disease worldwide. NAFLD can progress to serious complications such as cirrhosis, hepatocellular carcinoma and death. Therefore, it is important to recognise this condition so that early intervention can be implemented. Lifestyle modifications and strict control of metabolic risk factors are the mainstay of treatment. As disease progression is slow in the majority of NAFLD patients, most can be managed well by primary care physicians. NAFLD patients with advanced liver fibrosis should be referred to specialist care for further assessment. Copyright: © Singapore Medical Association.Entities:
Keywords: fibrosis; metabolic syndrome; non-alcoholic fatty liver disease
Mesh:
Year: 2016 PMID: 27439352 PMCID: PMC4958712 DOI: 10.11622/smedj.2016119
Source DB: PubMed Journal: Singapore Med J ISSN: 0037-5675 Impact factor: 1.858